BPS: Personalised Testing Must be Offered Throughout the NHS

This important publication from the British Pharmacological Society and the Royal College of Physicians sets out its recommendation that personalised prescribing through the use of pharmacogenomic testing be made available across the NHS to ensure all patients have an equal chance of being prescribed the right medicine, at the right dose, the first time.

“The UK is at the forefront of adoption of genomics in healthcare. This means we can be the first in the world to integrate pharmacogenomic testing into the NHS. This report provides the blueprint and identifies the resources and actions needed to ensure pharmacogenomics becomes usual care in the NHS over the next three years.”

— Professor Sir Mark Caulfield, Vice Principal for Health at Queen Mary University of London and President Elect of the British Pharmacological Society and contributor of the report

Click on the link below to read the full report: